• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form S-3MEF filed by Angi Inc.

    3/20/25 4:31:00 PM ET
    $ANGI
    Advertising
    Consumer Discretionary
    Get the next $ANGI alert in real time by email
    S-3MEF 1 tm254280d7_s3mef.htm S-3MEF

     

    As filed with the Securities and Exchange Commission on March 20, 2025

    Registration No. 333-

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

    Form S-3

    REGISTRATION STATEMENT

    UNDER

    THE SECURITIES ACT OF 1933

     

    ANGI INC.

    (Exact Name of Registrant as Specified in Its Charter)

     

    Delaware
    (State or Other Jurisdiction of
    Incorporation or Organization)
    82-1204801
    (I.R.S. Employer
    Identification Number)

     

    3601 Walnut Street, Denver, Colorado 80205

    Telephone: (303) 963-7200

    (Address, Including Zip Code, and Telephone Number, Including

    Area Code, of Registrant’s Principal Executive Offices)

     

    Shannon Shaw

    Chief Legal Officer
    Angi Inc.
    c/o IAC Inc.
    555 West 18th Street
    New York, New York 10011
    Telephone: (212) 314-7300

    (Name, Address, Including Zip Code, and Telephone Number, Including Area Code, of Agent for Service)

     

    Copy to:

     

    Andrew J. Nussbaum, Esq.

    Jenna E. Levine, Esq.

    Wachtell, Lipton, Rosen & Katz

    51 West 52nd Street

    New York, New York 10019

    (212) 403-1000

     

    Approximate date of commencement of proposed sale to the public:

    From time to time after the effective date of this Registration Statement.

     

    If the only securities being registered on this Form are being offered pursuant to dividend or interest reinvestment plans, please check the following box. ¨

     

    If any of the securities being registered on this Form are to be offered on a delayed or continuous basis pursuant to Rule 415 under the Securities Act of 1933, other than securities offered only in connection with dividend or interest reinvestment plans, check the following box. ¨

     

    If this Form is filed to register additional securities for an offering pursuant to Rule 462(b) under the Securities Act, please check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. x Registration No. 333-284531

     

    If this Form is a post-effective amendment filed pursuant to Rule 462(c) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. ¨

     

    If this Form is a registration statement pursuant to General Instruction I.D. or a post-effective amendment thereto that shall become effective upon filing with the Commission pursuant to Rule 462(e) under the Securities Act, check the following box. ¨

     

    If this Form is a post-effective amendment to a registration statement filed pursuant to General Instruction I.D. filed to register additional securities or additional classes of securities pursuant to Rule 413(b) under the Securities Act, check the following box. ¨

     

    Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

     

    Large accelerated filer x Accelerated filer ¨ Non-accelerated filer ¨

    Smaller reporting company ¨

    Emerging growth company ¨

     

    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. ¨

     

    This registration statement will become effective automatically upon filing with the Securities and Exchange Commission pursuant to Rule 462(b) under the Securities Act of 1933, as amended.

     

     

     

     

     

     

    EXPLANATORY NOTE AND INCORPORATION BY REFERENCE

     

    Angi Inc. (the “Company”) is filing this registration statement with the Securities and Exchange Commission (the “SEC”) pursuant to Rule 462(b) and General Instruction IV of Form S-3, both promulgated under the Securities Act of 1933, as amended (the “Securities Act”). This registration statement relates to the special dividend of securities of the Company by IAC Inc. to its stockholders, as contemplated by the registration statement on Form S-3 (Registration No. 333-284531), as amended, which was originally filed with the SEC on January 27, 2025 and declared effective on February 14, 2025 (the “Prior Registration Statement”).

     

    The Company is filing this registration statement for the sole purpose of increasing the aggregate amount of securities registered under the Prior Registration Statement by 2,000,000 shares of Class A common stock, par value $0.001 per share, of the Company (the “Angi Class A common stock”). The additional shares of Angi Class A common stock that are being registered for distribution hereunder are in an amount and at a price that together represent no more than 20% of the maximum aggregate offering price of securities registered under the Prior Registration Statement. Pursuant to Rule 462(b) of the Securities Act and General Instruction IV of Form S-3, the information set forth in the Prior Registration Statement, including all exhibits thereto and all information incorporated by reference therein, is incorporated by reference into this registration statement.

     

    The required opinions and consents are listed on the exhibit index and filed with this registration statement.

     

     

     

     

    EXHIBIT INDEX

     

    Exhibit
    Number
      Description
       
    5.1*   Opinion of Richards, Layton & Finger, P.A., as to the validity of the securities being registered.
       
    8.1*   Opinion of Wachtell, Lipton, Rosen & Katz, as to certain material U.S. federal tax matters.
       
    23.1*   Consent of Ernst & Young LLP, independent registered public accounting firm for the Company.
         
    23.2*   Consent of Richards, Layton & Finger, P.A. (included in Exhibit 5.1).
       
    23.3*   Consent of Wachtell, Lipton, Rosen & Katz (included in Exhibit 8.1).
       
    24.1**   Powers of Attorney.
       
    107*   Filing Fee Table.

     

    * Filed herewith.
    ** Previously filed with the Company’s Registration Statement on Form S-3 (Registration No. 333-284531), as amended, which was initially filed with the SEC on January 27, 2025.

     

    II-1 

     

     

    SIGNATURES

     

    Pursuant to the requirements of the Securities Act, the registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-3 and has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Boston, Commonwealth of Massachusetts, on this 20th day of March, 2025.

     

      Angi Inc.
         
      By: /s/ Jeffrey W. Kip
        Name: Jeffrey W. Kip
        Title: Chief Executive Officer

     

    Pursuant to the requirements of the Securities Act of 1933, as amended, this registration statement has been signed by the following persons in the capacities and on the dates indicated.

     

    Signature   Title   Date
             
    *   Chairman of the Board and Director   March 20, 2025
    Joseph Levin        
             
    /s/ Jeffrey W. Kip   Chief Executive Officer and Director   March 20, 2025
    Jeffrey W. Kip   (Principal Executive Officer)    
             
     /s/ Andrew Russakoff   Chief Financial Officer   March 20, 2025
    Andrew Russakoff   (Principal Financial Officer)      
             
    *   Chief Accounting Officer   March 20, 2025
    Julie Gosal Horau   (Principal Accounting Officer)    
             
    *   Director   March 20, 2025
    Thomas R. Evans        
             
    *   Director   March 20, 2025
    Alesia J. Haas        
             
    *   Director   March 20, 2025
    Christopher Halpin        
             
    *   Director   March 20, 2025
    Kendall F. Handler        
             
    *   Director   March 20, 2025
    Angela R. Hicks Bowman        
             
    *   Director   March 20, 2025
    Sandra Hurse        
             
    *   Director   March 20, 2025
    Jeremy G. Philips        
             
    *   Director   March 20, 2025
    Thomas C. Pickett Jr.        
             
    *   Director   March 20, 2025
    Glenn H. Schiffman        
             
    *   Director   March 20, 2025
    Mark Stein        
             
    *   Director   March 20, 2025
    Suzy Welch        

     

     

     

     

    *By:   /s/ Andrew Russakoff  
      Name: Andrew Russakoff  
      Title: Attorney-in-Fact  

     

     

     

    Get the next $ANGI alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $ANGI

    DatePrice TargetRatingAnalyst
    6/16/2025Mkt Outperform → Mkt Perform
    Citizens JMP
    12/18/2024Overweight → Neutral
    Analyst
    11/13/2024$3.25 → $2.50Buy → Neutral
    Goldman
    11/13/2024$3.25 → $2.00Buy → Neutral
    Citigroup
    7/9/2024$3.25Mkt Outperform
    JMP Securities
    2/15/2023$2.00 → $2.75Sell → Neutral
    UBS
    12/13/2022$2.60Buy
    Citigroup
    12/2/2022$2.00Sell
    UBS
    More analyst ratings

    $ANGI
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Angi Inc. downgraded by Citizens JMP

      Citizens JMP downgraded Angi Inc. from Mkt Outperform to Mkt Perform

      6/16/25 7:44:13 AM ET
      $ANGI
      Advertising
      Consumer Discretionary
    • Angi Inc. downgraded by Analyst

      Analyst downgraded Angi Inc. from Overweight to Neutral

      12/18/24 7:21:49 AM ET
      $ANGI
      Advertising
      Consumer Discretionary
    • Angi Inc. downgraded by Goldman with a new price target

      Goldman downgraded Angi Inc. from Buy to Neutral and set a new price target of $2.50 from $3.25 previously

      11/13/24 7:30:03 AM ET
      $ANGI
      Advertising
      Consumer Discretionary

    $ANGI
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • CEO Kip Jeffrey W bought $430,000 worth of shares (250,000 units at $1.72), increasing direct ownership by 37% to 917,331 units (SEC Form 4)

      4 - Angi Inc. (0001705110) (Issuer)

      11/18/24 4:12:18 PM ET
      $ANGI
      Advertising
      Consumer Discretionary